AGER and cancer: The receptor for advanced glycation end products (RAGE) is a transmembrane receptor belonging to the immunoglobulin superfamily that has been implicated in various pathological processes, including cancer, diabetes, and neurodegenerative conditions such as Alzheimer’s disease [6,7,8,9].